Oligonucleotide analog and method for treating flavivirus infections

Details for Australian Patent Application No. 2004276226 (hide)

Owner AVI BioPharma, Inc.

Inventors Iversen, Patrick L.; Stein, David A.

Agent FB Rice

Pub. Number AU-B-2004276226

PCT Pub. Number WO2005/030800

Priority 60/493,043 05.08.03 US; 60/512,003 16.10.03 US

Filing date 5 August 2004

Wipo publication date 7 April 2005

Acceptance publication date 30 July 2009

International Classifications

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

Event Publications

16 February 2006 PCT application entered the National Phase

  PCT publication WO2005/030800 Priority application(s): WO2005/030800

30 July 2009 Application Accepted

  Published as AU-B-2004276226

26 November 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004276227-Oxygen scavenger compositions derived from isophthalic acid and/or terephthalic acid monomers or derivatives thereof

2004276221-A wear-resistant member having a hard composite comprising hard constituents held in an infiltrant matrix